Showing results (11-20 of 616) with videos related to
Sort By:
Pageof 62
Current Hematology Reports|December 22, 2004
Farnesyltransferase inhibitor therapy in acute myelogenous leukemiaJason GotlibCurrent Hematologic Malignancy Reports|September 26, 2015
Tyrosine Kinase Inhibitors and Therapeutic Antibodies in Advanced Eosinophilic Disorders and Systemic MastocytosisJason GotlibAmerican Journal of Hematology|October 22, 2015
World Health Organization-defined eosinophilic disorders: 2015 update on diagnosis, risk stratification, and managementJason GotlibActa Haematologica|July 5, 2005
Molecular classification and pathogenesis of eosinophilic disorders: 2005 updateJason GotlibHematology. American Society of Hematology. Education Program|December 9, 2022
Available and emerging therapies for bona fide advanced systemic mastocytosis and primary eosinophilic neoplasmsJason GotlibHematology. American Society of Hematology. Education Program|December 10, 2013
JAK inhibition in the myeloproliferative neoplasms: lessons learned from the bench and bedsideJason GotlibCurrent Opinion in Hematology|January 15, 2010
Eosinophilic myeloid disorders: new classification and novel therapeutic strategiesJason GotlibHematology/Oncology Clinics of North America|July 5, 2017
Tyrosine Kinase Inhibitors in the Treatment of Eosinophilic Neoplasms and Systemic MastocytosisJason GotlibAmerican Journal of Hematology|October 19, 2017
World Health Organization-defined eosinophilic disorders: 2017 update on diagnosis, risk stratification, and managementJason GotlibImmunology and Allergy Clinics of North America|August 26, 2006
KIT mutations in mastocytosis and their potential as therapeutic targetsJason GotlibPageof 62